Jacobs Levy Equity Management Inc. Purchases Shares of 305,239 DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Jacobs Levy Equity Management Inc. purchased a new stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 305,239 shares of the medical instruments supplier's stock, valued at approximately $5,793,000. Jacobs Levy Equity Management Inc. owned about 0.15% of DENTSPLY SIRONA at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Gotham Asset Management LLC increased its position in shares of DENTSPLY SIRONA by 8.5% during the fourth quarter. Gotham Asset Management LLC now owns 770,809 shares of the medical instruments supplier's stock worth $14,630,000 after purchasing an additional 60,111 shares in the last quarter. Focus Partners Wealth purchased a new position in shares of DENTSPLY SIRONA in the 4th quarter valued at approximately $300,000. Engine Capital Management LP grew its position in DENTSPLY SIRONA by 123.3% in the 4th quarter. Engine Capital Management LP now owns 706,401 shares of the medical instruments supplier's stock valued at $13,407,000 after buying an additional 390,000 shares during the last quarter. Deutsche Bank AG grew its position in DENTSPLY SIRONA by 29.7% in the 4th quarter. Deutsche Bank AG now owns 15,720 shares of the medical instruments supplier's stock valued at $298,000 after buying an additional 3,603 shares during the last quarter. Finally, D. E. Shaw & Co. Inc. increased its stake in DENTSPLY SIRONA by 936.9% in the 4th quarter. D. E. Shaw & Co. Inc. now owns 997,415 shares of the medical instruments supplier's stock valued at $18,931,000 after buying an additional 901,224 shares during the period. 95.70% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at DENTSPLY SIRONA

In other news, Director Gregory T. Lucier bought 15,142 shares of the firm's stock in a transaction that occurred on Monday, March 3rd. The shares were purchased at an average price of $16.51 per share, for a total transaction of $249,994.42. Following the completion of the transaction, the director now owns 81,971 shares in the company, valued at $1,353,341.21. The trade was a 22.66% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Insiders own 0.50% of the company's stock.

DENTSPLY SIRONA Price Performance

XRAY traded down $0.16 during trading on Monday, reaching $16.55. 330,329 shares of the stock were exchanged, compared to its average volume of 2,958,552. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84. The company has a market capitalization of $3.30 billion, a price-to-earnings ratio of -7.99, a P/E/G ratio of 1.80 and a beta of 0.92. DENTSPLY SIRONA Inc. has a 1 year low of $12.16 and a 1 year high of $28.44. The business's 50 day moving average price is $14.41 and its two-hundred day moving average price is $17.30.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last issued its quarterly earnings data on Thursday, May 8th. The medical instruments supplier reported $0.43 EPS for the quarter, beating analysts' consensus estimates of $0.29 by $0.14. The firm had revenue of $879.00 million for the quarter, compared to analysts' expectations of $854.75 million. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The firm's revenue was down 7.8% on a year-over-year basis. During the same period in the prior year, the company earned $0.42 EPS. As a group, equities research analysts anticipate that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current year.

DENTSPLY SIRONA Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, April 11th. Shareholders of record on Friday, March 28th were given a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a yield of 3.87%. The ex-dividend date of this dividend was Friday, March 28th. DENTSPLY SIRONA's payout ratio is -14.10%.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on the stock. Wells Fargo & Company reduced their target price on shares of DENTSPLY SIRONA from $20.00 to $19.00 and set an "equal weight" rating for the company in a research note on Friday, February 28th. Needham & Company LLC reissued a "hold" rating on shares of DENTSPLY SIRONA in a report on Thursday, March 13th. StockNews.com raised DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a report on Friday, May 9th. Morgan Stanley cut DENTSPLY SIRONA from an "overweight" rating to an "equal weight" rating and set a $14.00 target price on the stock. in a research report on Tuesday, April 15th. Finally, Barrington Research raised their price target on DENTSPLY SIRONA from $20.00 to $21.00 and gave the company an "outperform" rating in a report on Monday, May 12th. Eleven equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of "Hold" and an average price target of $20.36.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.